|
| Status |
Public on Nov 21, 2014 |
| Title |
Targeting of Super-Enhancer-Associated Oncogenic Transcription in MYCN-driven tumor cells by CDK7 inhibition [ChIP-Seq] |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
ChIP-seq for Pol II, H3K27ac and H3K4me1 in neuroblastoma
|
| |
|
| Overall design |
ChIP-seq for Pol II, H3K27ac and H3K4me1 in neuroblastoma
|
| |
|
| Contributor(s) |
Chipumuro E, Marco E, Kwiatkowski N, Abraham B, George R |
| Citation(s) |
25416950 |
| Submission date |
Oct 27, 2014 |
| Last update date |
May 15, 2019 |
| Contact name |
Rani George |
| E-mail(s) |
Rani_George@dfci.harvard.edu
|
| Phone |
617-632-5281
|
| Organization name |
Dana Farber Cancer Institute
|
| Department |
Pediatric Oncology
|
| Lab |
Rani George Lab
|
| Street address |
450 Brookline Ave
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02115 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL9052 |
Illumina Genome Analyzer (Homo sapiens) |
|
| Samples (18)
|
|
| This SubSeries is part of SuperSeries: |
| GSE62726 |
Targeting of Super-Enhancer-Associated Oncogenic Transcription in MYCN-driven tumor cells by CDK7 inhibition |
|
| Relations |
| BioProject |
PRJNA264969 |
| SRA |
SRP049295 |
Less...
More...